Skip to content

Multiomics study of intrahepatic cholestasis of pregnancy

Multiomics study of intrahepatic cholestasis of pregnancy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063574
Enrollment
Unknown
Registered
2022-09-12
Start date
2022-09-18
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrahepatic cholestasis of pregnancy

Interventions

Sponsors

Chengdu Women's and Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Pregnant women with ICP (fasting TBA > 10 µM); Ursodeoxycholic acid was not taken; Single child; Natural conception; Agree to sign informed consent.

Exclusion criteria

Exclusion criteria: Including: suffering from high blood pressure, thyroid disease, kidney disease, gestational diabetes, premature rupture of membranes, preterm delivery, preeclampsia, hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome, pregnancy with acute fatty liver, primary biliary cirrhosis, viral hepatitis and any ultrasound may lead to abnormal biliary obstruction.

Design outcomes

Primary

MeasureTime frame
RNA;protein;peptide;

Countries

China

Contacts

Public ContactXiao Yang
wcchgcptg@163.com+86 028-61866009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026